DermBiont

DermBiont's mission is to become the world's leading precision dermatology company, developing and commercializing targeted topical therapies for the treatment, cure, and prevention of skin diseases. The company aims to fundamentally treat skin conditions by developing first-in-class targeted therapeutics with clear mechanisms of action. Its targeted topical treatment pipeline includes two key assets: SM-020 for the treatment of seborrheic keratosis and SM-030 for melasma and other skin pigmentation disorders.